Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast

D Mitra, S Bhattacharyya, N Alam, S Sen… - Breast Cancer Research …, 2020 - Springer
Purpose The occurrence of vasculogenic mimicry (VM) and EphA2-mediated tumour
progression are associated with poor prognosis in various solid tumours. Here, we aimed to …

Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast

M Debarpan, B Sayantan, A Neyaz… - Breast Cancer …, 2020 - search.proquest.com
Purpose The occurrence of vasculogenic mimicry (VM) and EphA2-mediated tumour
progression are associated with poor prognosis in various solid tumours. Here, we aimed to …

Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast.

D Mitra, S Bhattacharyya, N Alam, S Sen… - … Cancer Research and …, 2020 - go.gale.com
Purpose The occurrence of vasculogenic mimicry (VM) and EphA2-mediated tumour
progression are associated with poor prognosis in various solid tumours. Here, we aimed to …

Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast

D Mitra, S Bhattacharyya, N Alam… - Breast cancer …, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose The occurrence of vasculogenic mimicry (VM) and EphA2-mediated tumour
progression are associated with poor prognosis in various solid tumours. Here, we aimed to …

Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast.

D Mitra, S Bhattacharyya, N Alam, S Sen… - … Cancer Research and …, 2019 - europepmc.org
PURPOSE: The occurrence of vasculogenic mimicry (VM) and EphA2-mediated tumour
progression are associated with poor prognosis in various solid tumours. Here, we aimed to …